Deferred Tax Assets, Valuation Allowance of Roivant Sciences Ltd. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Roivant Sciences Ltd. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2021 to 31 Mar 2025.
Roivant Sciences Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $701,219,000, a 25% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Roivant Sciences Ltd. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$701,219,000	+$142,351,000	+25%	31 Mar 2025	10-K	29 May 2025	2024	FY
Q1 2024	$558,868,000	-$115,649,000	-17%	31 Mar 2024	10-K	29 May 2025	2024	FY
Q1 2023	$674,517,000	+$161,781,000	+32%	31 Mar 2023	10-K	30 May 2024	2023	FY
Q1 2022	$512,736,000	+$209,449,000	+69%	31 Mar 2022	10-K	28 Jun 2023	2023	FY
Q1 2021	$303,287,000			31 Mar 2021	10-K	28 Jun 2022	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.